Search - tctmd.com

Displaying 481 - 500 of 1615

Sort: Relevancy | Date

Presentation TCT 2023

One-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results

Presenter: Firas Zahr

October 24, 2023

Presentation TCT 2023

TMVR Design Iteration and Patient Eligibility

Presenter: Juan Granada

October 24, 2023

Presentation TCT 2023

Are Outcome Trials Necessary for Renal Denervation Therapies?

Presenter: Ajay Kirtane

October 24, 2023

Presentation TCT 2023

LVOT Obstruction Prevention and Management

Presenter: Robert Lederman

October 24, 2023

Presentation TCT 2023

What Will the Next Trial Designs Look Like for Renal Denervation?

Presenter: Eric Secemsky

October 24, 2023

Presentation TCT 2023

Advances in Imaging Pre-Screening and Patient Selection

Presenter: Joao Cavalcante

October 24, 2023

Presentation TCT 2023

Leaflet Excision: The Complete Solution (Excision Medical Inc)

Presenter: D. Scott Lim

October 24, 2023

Presentation TCT 2023

Clinician Perspectives

Presenter: Naomi Fisher

October 24, 2023

Presentation TCT 2023

Industry Perspectives

Presenter: Sandeep Brar

October 24, 2023

Presentation TCT 2023

Trans-Esophageal Imaging to Direct and Document Leaflet Splitting Procedures During Valve-in-Valve TAVR

Presenter: Philippe Pibarot

October 24, 2023

Presentation TCT 2023

Trialist Perspectives

Presenter: Felix Mahfoud

October 24, 2023

Presentation TCT 2023

A Novel Transfemoral Aortic Valve Replacement System (Hanchor Valve) for Pure Native Aortic Regurgitation (PNAR)

Presenter: Wenzhi Pan

October 24, 2023

Presentation TCT 2023

Implications for RCTs and Work Force Considerations

Presenter: Roxana Mehran

October 24, 2023

Presentation TCT 2023

DurAVR Transcatheter Heart Valve: Early Feasibility Study

Presenter: Azeem Latib

October 24, 2023

Presentation TCT 2023

Robotically Developed Polymeric-Based Leaflet Technology (Foldax): Technology and Clinical Program Update

Presenter: Isaac George

October 24, 2023

Presentation TCT 2023

Comparison of Two Self-Expanding Transcatheter Heart Valves for Degenerated Surgical Bioprostheses: The AVENGER Multi-Center Registry

Presenter: Won-Keun Kim

October 24, 2023

Presentation TCT 2023

FDA DEI Initiatives

Presenter: Jaime Raben

October 24, 2023

Presentation TCT 2023

One-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From EXPAND G4

Presenter: Ralph Stephan von Bardeleben

October 24, 2023

Presentation TCT 2023

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

Presenter: Roberto Galea

October 24, 2023

Presentation TCT 2023

TRILUMINATE Pivotal: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation

Presenter: David Adams

October 24, 2023

Advertisement

One-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results

TMVR Design Iteration and Patient Eligibility

Are Outcome Trials Necessary for Renal Denervation Therapies?

LVOT Obstruction Prevention and Management

What Will the Next Trial Designs Look Like for Renal Denervation?

Advances in Imaging Pre-Screening and Patient Selection

Leaflet Excision: The Complete Solution (Excision Medical Inc)

Clinician Perspectives

Industry Perspectives

Trans-Esophageal Imaging to Direct and Document Leaflet Splitting Procedures During Valve-in-Valve TAVR

Trialist Perspectives

A Novel Transfemoral Aortic Valve Replacement System (Hanchor Valve) for Pure Native Aortic Regurgitation (PNAR)

Implications for RCTs and Work Force Considerations

DurAVR Transcatheter Heart Valve: Early Feasibility Study

Robotically Developed Polymeric-Based Leaflet Technology (Foldax): Technology and Clinical Program Update

Comparison of Two Self-Expanding Transcatheter Heart Valves for Degenerated Surgical Bioprostheses: The AVENGER Multi-Center Registry

FDA DEI Initiatives

One-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From EXPAND G4

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

TRILUMINATE Pivotal: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content